Shore Capital Partners has launched Agentis Longevity, a new, innovative platform dedicated to advancing comprehensive longevity healthcare.
Based in Nashville, USA, Agentis aims to redefine healthy ageing by delivering a suite of services designed to extend health span and address age-related conditions.
Agentis will focus on delivering comprehensive care to its patients, including hormone optimisation therapy, health testing, weight management, peptides, stem cells and other innovative therapies.
“The longevity marketplace is primed for bold leadership, and I am inspired by the opportunity to help people live a life of wellness while addressing unmet needs in healthcare,” said Jimmy St Louis, veteran healthcare operator and Agentis CEO.
“The name Agentis is indicative of taking powerful action to make a difference for our patients and family members, and this journey is deeply personal to me. Coming from a medical family, I am driven by the belief that quality of life and length of life should go hand in hand.
“Partnering with Shore Capital is a dream realised—it brings the resources, expertise and support needed to truly make a transformative difference in the lives of healthcare consumers. Together, we are shaping a future where vitality and innovation meet to empower healthier, happier lives.”
“The goal of Agentis is to empower patients to take ownership of their health to live longer, happier and healthier lives,” said Logan Pitts, vice president at Shore.
“We’ve found that American consumers are increasingly motivated to prioritise proactively managing their health, whether it be how they feel or how they look, and we are excited to announce another Shore platform investment aligned with the growing theme of consumerisation in healthcare.”
Chris Mioton, partner at Shore, added: “We believe that the early-stage growth of the consumer longevity market presents an opportunity to become a national leader.
“By combining cutting-edge services and products with robust clinical practices and education, we see a tremendous opportunity to shape the future of longevity healthcare.”
